Table 5. Outcomes of adult patients with severe Corynebacterium striatum and methicillin-resistant Staphylococcus aureus pneumonia, Seoul, South Korea, 2014–2019*.

Outcome	Total, n = 130	C. striatum, n = 27	MRSA, n = 103	p value
Death
Total	n = 103	n = 27	n = 103	NA
30 days	41 (31.5)	11 (40.7)	30 (29.1)	0.25
60 days	57 (43.8)	14 (48.1)	44 (42.7)	0.61
90 days	68 (52.3)	16 (59.3)	52 (50.5)	0.42
In-hospital	73 (56.2)	19 (70.4)	54 (52.4)	0.09
Death among patient categories
Nonimmunocompromised patients	n = 89	n = 13	n = 76	NA
30 days	21 (23.6)	5 (38.5)	16 (21.1)	0.18
60 days	31 (34.8)	5 (38.5)	26 (34.2)	0.76
90 days	40 (44.9)	7 (53.8)	33 (43.4)	0.49
In-hospital	40 (44.9)	7 (53.8)	33 (43.4)	0.49
Immunocompromised patients	n = 41	n = 14	n = 27	NA
30 days	20 (48.8)	6 (42.9)	14 (51.9)	0.59
60 days	26 (63.4)	8 (57.1)	18 (66.7)	0.55
90 days	28 (68.3)	9 (64.3)	19 (70.4)	0.73
In-hospital	33 (80.5)	12 (85.7)	21 (77.8)	0.69
Median ICU stay, d (IQR)	14.0 (8.0–26.3)	14.0 (9.0–27.0)	14.0 (8.0–26.0)	0.33
Median hospital stay after ICU admission, d (IQR)	29.5 (14.0–57.0)	30.0 (16.0–81.0)	29.0 (14.0–55.0)	0.48

*Values are no. (%) except as indicated. ICU, intensive care unit; MRSA, methicillin-resistant Staphylococcus aureus; NA, not applicable.